HTHT
VRTX icon

Hemenway Trust Hemenway Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23M Buy
51,499
+482
+0.9% +$225K 1.85% 24
2025
Q4 		$23.1M Sell
51,017
-4,108
-7% -$1.77M 1.77% 22
2025
Q3 		$21.6M Sell
55,125
-390
-0.7% -$163K 1.65% 24
2025
Q2 		$24.7M Buy
55,515
+1,191
+2% +$549K 1.91% 23
2025
Q1 		$26.3M Buy
54,324
+4,911
+10% +$2.29M 2.14% 23
2024
Q4 		$19.9M Buy
49,413
+9,294
+23% +$4.31M 1.61% 26
2024
Q3 		$18.7M Buy
40,119
+11,682
+41% +$5.61M 1.48% 28
2024
Q2 		$13.3M Buy
28,437
+12,919
+83% +$5.61M 1.14% 30
2024
Q1 		$6.49M Buy
15,518
+10,835
+231% +$4.58M 0.56% 35
2023
Q4 		$1.91M Buy
4,683
+917
+24% +$339K 0.18% 46
2023
Q3 		$1.31M Buy
3,766
+40
+1% +$14K 0.14% 63
2023
Q2 		$1.31M Buy
3,726
+185
+5% +$62.3K 0.13% 63
2023
Q1 		$1.12M Sell
3,541
-5
-0.1% -$1.5K 0.12% 64
2022
Q4 		$1.02M Buy
3,546
+125
+4% +$38.1K 0.11% 72
2022
Q3 		$991K Buy
3,421
+890
+35% +$256K 0.12% 70
2022
Q2 		$713K Buy
2,531
+1,110
+78% +$297K 0.08% 75
2022
Q1 		$371K Hold
1,421
– – 0.04% 103
2021
Q4 		$312K Hold
1,421
– – 0.03% 110
2021
Q3 		$258K Buy
+1,421
New +$277K 0.03% 123

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Hemenway Trust Hemenway Trust's VRTX Position: Q1 2026 in Review

Hemenway Trust Hemenway Trust increased its Vertex Pharmaceuticals (VRTX) stake by 0.94% in Q1 2026, buying an estimated $225K and bringing the position to 51,499 shares worth $23M. The position accounts for 1.85% of the portfolio, ranked #24.

Hemenway Trust Hemenway Trust first reported a position in VRTX in Q3 2021 and has held it in 19 quarters since. The position peaked at $26.3M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Hemenway Trust Hemenway Trust held 51,499 shares of Vertex Pharmaceuticals worth $23M as of Q1 2026.
  • Hemenway Trust Hemenway Trust bought 482 Vertex Pharmaceuticals shares in Q1 2026, an estimated $225K.
  • Vertex Pharmaceuticals made up 1.85% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #24 holding.
  • Hemenway Trust Hemenway Trust first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Hemenway Trust Hemenway Trust's Vertex Pharmaceuticals position peaked at $26.3M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.